Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-741-5 | CAS number: 149-45-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 - 20 Sep 2005
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Adopted in 2002
- Deviations:
- yes
- Remarks:
- Purity of the test item was not stated in the report
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Adopted in 2010
- GLP compliance:
- not specified
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Disodium 4,5-dihydroxybenzene-1,3-disulphonate
- EC Number:
- 205-741-5
- EC Name:
- Disodium 4,5-dihydroxybenzene-1,3-disulphonate
- Cas Number:
- 149-45-1
- Molecular formula:
- C6H6O8S2.2Na
- IUPAC Name:
- disodium 4,5-dihydroxybenzene-1,3-disulphonate
- Test material form:
- solid: particulate/powder
- Remarks:
- white powder
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Jackson Labouratories, Bar Harbour, Maine, USA
- Females: yes
- Age at study initiation: 10-11 weeks
- Weight at study initiation: 17-25 g (range)
- Housing: individually, no further details in the report
- Diet: Certified Rodent Chow 7012C, ad libitum
- Water: tap water via water bottles, ad libitum
- Acclimation period: at least 6 days
- Indication of any skin lesions: only suitable animals, as determined by veterinary staff, were assigned
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.25 ± 5.55
- Humidity (%): 29-49
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (LLNA)
- Vehicle:
- other: 30:70 ethanol:water
- Concentration:
- 1, 5, and 15% (w/v)
- No. of animals per dose:
- 5
- Details on study design:
- JUSTIFICATION FOR DOSE LEVEL
The dose levels were specified by the sponsor and are documented in the raw data.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT:
- Name of test method: ³H-methyl thymidine determined by β-scintillation
- Criteria used to consider a positive response: A stimulation index ≥3.0 relative to the concurrent vehicle treated control, is regarded as a positive response.
TREATMENT PREPARATION AND ADMINISTRATION:
Groups of 5 mice were treated on the dorsal surface of both ears once per day for 3 days with 25 µL (per ear) of 1, 5, or 15% (w/v) of test substance in vehicle, with the vehicle (30:70 ethanol:water), with the vehicle for the positive control (acetone:olive oil, 4:1 [AOO]), or with the positive control (HCA at 35% [v/v]). Local irritation reactions, mortality and systemic toxicity were assessed daily. On Day 6, the mice were injected intravenously (tail vein) with 20 µCi of ³H-methyl thymidine in 250 µL of sterile saline. Five hours later, the mice were euthanised and the draining auricular lymph nodes were removed. A single cell suspension was prepared from the lymph nodes of each mouse. Cells were washed twice with phosphate buffered saline and precipitated with 5% trichloroacetic acid (TCA) overnight at 2-8 °C. Pellets were recovered by centrifugation and were counted in a β-scintillation counter to determine the incorporation of ³H-methyl thymidine. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- DPM data was analysed using SAS by log transformation of the data. Comparisons with the control group were based on the least significant difference criterion, with all tests conducted at a 1%, two-tailed probability level.
BW and change in BW means and SEM were calculated for each group. Evaluations were made by one way ANOVA using the F distribution to assess statistical significance, and where found, a Dunnett's test was used to determine the degree of significance from the control mean.
Results and discussion
- Positive control results:
- Exposure to the positive control, 35% HCA (v/v) in the AOO vehicle, resulted in a stimulation index (SI) of 8.3 indicating a positive response. This response was also statistically significant when compared to the AOO vehicle control group (p = 0.0001). This SI value showed the effectiveness of the positive control treatment in this assay.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.79
- Variability:
- pooled results per group
- Test group / Remarks:
- 1% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 1.18
- Variability:
- pooled results per group
- Test group / Remarks:
- 5% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 1.03
- Variability:
- pooled results per group
- Test group / Remarks:
- 15% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 7.98
- Variability:
- pooled results per group
- Test group / Remarks:
- positive control
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX (SI) CALCULATION:
The SI ratio was calculated as the mean DPM value measured per dosage level of treated lymph nodes, over the mean DPM value measured for the control group: SI = Test/control ratio.
Group Concentration % (w/v) DPM Number of lymph nodes DPM/node Test/control (+) = positive
ratio (-) = negative
1 Vehicle control 230.504 5 46.101 NA NA Vehicle control
2 1 412.502 5 82.500 1.789 (-) Test substance
3 5 272.034 5 54.407 1.180 (-) Test substance
4 15 237.896 5 47.579 1.032 (-) Test substance
5 HCA (35% [v/v]) 1914.596 5 382.91 7.98 (+) Positive control
CLINICAL OBSERVATIONS:
There was no mortality and all animals appeared normal throughout the study. The application sites on the mice treated with the test substance at a concentration of 15% exhibited very slight erythema and very slight edema on Day 3.
BODY WEIGHTS:
BW and change in BW means were evaluated and no statistically significant differences were observed between any of the groups of treated animals.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.